Background illustration for clinical trials search

Paid Clinical Trials Missouri

Discover 1,770 paid clinical trials in Missouri. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia

for
Bradykinesia
Location: Brentwood TN, Paducah KY, Chesterfield MO
Sponsor: IMAC Holdings, Inc.

Sex: All

Age: 55+

Code: NCT04385056

Phase1, Recruiting
New

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

for
HIV-1-infection
Location: West Palm Beach FL, Ft. Pierce FL, Decatur GA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07708727

Phase2, Phase3, Recruiting
New

Alleviant ALLAY-HF Study

for
Heart Failure
Location: Boston MA, Stony Brook NY, Montreal, New York NY,
Sponsor: Alleviant Medical, Inc.

Sex: All

Age: 40+

Code: NCT05685303

Recruiting
New

ENGAGE-TBI Feasibility Study

for
TBI (Traumatic Brain Injury)
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07549997

Phase1, Recruiting
New

Feasibility of SUPPORT-TBI

for
TBI Traumatic Brain Injury
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07625098

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

for
Alzheimer's Disease
Location: Methuen MA, Willow Grove PA, Ottawa, Atlantis FL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT07094516

Phase2, Recruiting
New

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for
Small Cell Lung Cancer (SCLC ),
Location: New York NY, Hackensack NJ, Nashville TN, St Louis MO,
Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase1, Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting
Featured

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer
Location: Levis, Greenfield Park, Montreal, Brampton,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT04928846

Phase3, Recruiting
Featured

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for
Chronic Lymphocytic Leukemia
Location: Providence RI, Worcester MA, New Haven CT, New York NY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06428019

Phase3, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase2, Recruiting
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: New Bedford MA, New Haven CT, Quebec, Danbury CT,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Boston MA, Dracut MA, Nashua NH, Smithtown NY,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for
Bipolar I Disorder, Bipolar II Disorder
Location: New York NY, Pompano Beach FL, West Palm Beach FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase2, Recruiting

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Johnston RI, Quebec, Miramar FL, Miami FL, Toronto,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase2, Recruiting
FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Springfield MA, Brooklyn NY, Toms River NJ,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting
FeaturedActive & Responsive

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

for
Bipolar I or II Disorder
Location: Cromwell CT, Springfield MA, Cedarhurst NY, Brooklyn NY,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07220460

Phase2, Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for
Radiographic Axial Spondyloarthritis
Location: Quebec, Trois-Rivieres, Philadelphia PA, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07133633

Phase2, Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase3, Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Quebec, New York NY, Norfolk VA, Morehead City NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

Popular cities in Missouri

With its expansive healthcare network and renowned medical research institutions, Missouri is a central hub for a diverse range of clinical trials. Leading organizations such as Washington University School of Medicine in St. Louis, the University of Missouri Health Care, and St. Louis University are at the forefront of groundbreaking studies. These institutions drive innovation in medical research and offer unique opportunities for participants to engage in cutting-edge clinical trials, contributing to advancements in healthcare both locally and nationwide.

Why choose Missouri for clinical trials?

Missouri has a diverse population which ensures a wide variety of participants can take part in clinical trials, enhancing the accuracy, applicability, and validity of clinical research findings. The state is also home to a thriving research environment, with a strong emphasis on medical innovation and cutting-edge studies led by world-class institutions.

By choosing to participate in a clinical trial in Missouri, individuals contribute to critical advancements in medical research while benefiting from a well-established and supportive clinical research infrastructure.

Common conditions studied in Missouri

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Missouri